Arvinas, Inc. (ARVN)
Arvinas Market Cap : 442.78M for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 446.71M |
| November 12, 2026 | 449.98M |
| November 11, 2026 | 452.60M |
| November 10, 2026 | 453.26M |
| November 09, 2026 | 442.78M |
| November 06, 2026 | 419.86M |
| November 05, 2026 | 429.02M |
| November 04, 2026 | 486.01M |
| November 03, 2026 | 464.40M |
| November 02, 2026 | 492.56M |
| October 30, 2026 | 514.83M |
| October 29, 2026 | 517.45M |
| October 28, 2026 | 496.28M |
| October 27, 2026 | 486.48M |
| October 26, 2026 | 477.34M |
| October 23, 2026 | 476.69M |
| October 22, 2026 | 504.12M |
| October 21, 2026 | 493.34M |
| October 20, 2026 | 500.20M |
| October 19, 2026 | 474.08M |
| October 16, 2026 | 455.14M |
| October 15, 2026 | 467.55M |
| October 14, 2026 | 445.35M |
| October 13, 2026 | 446.65M |
| October 12, 2026 | 486.48M |
| Date | Value |
|---|---|
| October 09, 2026 | 498.89M |
| October 08, 2026 | 490.40M |
| October 07, 2026 | 486.48M |
| October 06, 2026 | 477.34M |
| October 05, 2026 | 487.14M |
| October 02, 2026 | 483.87M |
| October 01, 2026 | 485.18M |
| September 30, 2026 | 505.10M |
| September 29, 2026 | 489.75M |
| September 28, 2026 | 490.40M |
| September 25, 2026 | 495.63M |
| September 24, 2026 | 508.69M |
| September 23, 2026 | 511.30M |
| September 22, 2026 | 555.70M |
| September 21, 2026 | 541.99M |
| September 18, 2026 | 541.34M |
| September 17, 2026 | 542.64M |
| September 16, 2026 | 532.85M |
| September 15, 2026 | 539.38M |
| September 14, 2026 | 548.52M |
| September 11, 2026 | 551.78M |
| September 10, 2026 | 568.76M |
| September 09, 2026 | 572.03M |
| September 08, 2026 | 592.92M |
| September 04, 2026 | 613.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.51M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0407M |
| Fulcrum Therapeutics, Inc. | 284.54M |
| Definium Therapeutics, Inc. | 4.126B |
Market Cap Related Metrics
| PS Ratio | 1.596 |
| Price to Book Value | 0.8618 |
| Price | 6.76 |
| Earnings Yield | -2.73% |